Literature DB >> 9150741

Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q.

D F Barker1, J C Denison, C L Atkin, M C Gregory.   

Abstract

Mutations in the basement membrane collagen gene COL4A5 cause the progressive renal glomerular nephropathy and typical hearing loss that occur in X-linked Alport syndrome. Nearly all cases involve distinct mutations, as expected for an X-linked disease that significantly reduces the fitness of affected males. A few exceptional COL4A5 mutations appear to be associated with a reduced disease severity and may account for a significant proportion of late-onset Alport syndrome in populations where a founder effect has occurred. The novel mutation reported here, COL4A5 arg1677gln, has been detected in three independently ascertained Ashkenazi-American families, causes a relatively mild form of nephritis with typical onset in the fourth or fifth decade, and may be involved in the etiology of a large proportion of adult-onset hereditary nephritis in Ashkenazi Jews.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150741     DOI: 10.1007/s004390050429

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

2.  COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.

Authors:  Helen Storey; Judy Savige; Vanessa Sivakumar; Stephen Abbs; Frances A Flinter
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

3.  Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.

Authors:  Kaya L Andrews; Jacqueline L Mudd; Cong Li; Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

4.  Pathogenicity of missense variants affecting the collagen IV α5 carboxy non-collagenous domain in X-linked Alport syndrome.

Authors:  Joel T Gibson; Omid Sadeghi-Alavijeh; Daniel P Gale; Hansjörg Rothe; Judy Savige
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

5.  Molecular testing for adult type Alport syndrome.

Authors:  Genevieve Pont-Kingdon; Kelli Sumner; Friederike Gedge; Chris Miller; Joyce Denison; Martin Gregory; Elaine Lyon
Journal:  BMC Nephrol       Date:  2009-11-17       Impact factor: 2.388

6.  A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.

Authors:  Ron Korstanje; Christina R Caputo; Rosalinda A Doty; Susan A Cook; Roderick T Bronson; Muriel T Davisson; Jeffrey H Miner
Journal:  Kidney Int       Date:  2014-02-12       Impact factor: 10.612

7.  X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.

Authors:  Judith Savige; Helen Storey; Hae Il Cheong; Hee Gyung Kang; Eujin Park; Pascale Hilbert; Anton Persikov; Carmen Torres-Fernandez; Elisabet Ars; Roser Torra; Jens Michael Hertz; Mads Thomassen; Lev Shagam; Dongmao Wang; Yanyan Wang; Frances Flinter; Mato Nagel
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

8.  Transposon clusters as substrates for aberrant splice-site activation.

Authors:  Maria Elena Vilar Alvarez; Martin Chivers; Ivana Borovska; Steven Monger; Eleni Giannoulatou; Jana Kralovicova; Igor Vorechovsky
Journal:  RNA Biol       Date:  2020-09-23       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.